1266245-41-3

Upstream product

• 1266244-86-3 trifluoro-methanesulphonic acid 2-methyl-3-oxo-2,3-dihydro-pyridazin-4-yl ester 
• 1266244-66-9 (R)-2-amino-1-[4-(2-chloro-5-trifluoromethyl-phenoxy)-piperidin-1-yl]-propan-1-one 
• 77541-59-4 5-chloro-4-methoxy-2-methyl-3(2H)-pyridazinone 
• 933-76-6 4,5-dichloro-2-methyl-3(2H)-pyridazinone 

Relevant academic research and scientific papers

DERIVATIVES OF 2H PYRIDAZIN- 3 -ONES, THEIR PREPARATION AND THEIR USE AS SCD-1 INHIBITORS

The present invention concerns compounds of general formula (I) characterized in that (formula 1) wherein, in particular: -R1 represents one or more groups such as: trif luoromethyl, halogen such as F, C1, -when n=m=1, W represents CH then Y represents oxygen, -U represents: ? either - (C=O) CH2NH- and is branched at position 4 of pyridazinone, then R2 represents H, ? or -(C=O)NH- and U is branched at positions (4), (5) or (6) of pyridazinone, then R2 represents H, - R3 represents a hydrogen or methyl and the addition salts with pharmaceutically acceptable bases and acids and the different isomers, and their mixtures in any proportion for use as SCD-1 enyzme inhibitors for the treatment of obesitz, tzpe-2 diabetes and lipid disorders.